Consensus/ancestral immunogens
US10946090B2 · kind B2 · utility
0Cited by
6References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 15, 2017 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | Nov 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to an immunogen and, in particular, to an immunogen for inducing antibodies that neutralizes a wide spectrum of HIV primary isolates and/or to an immunogen that induces a T cell immune response. The invention also relates to a method of inducing anti-HIV antibodies, and/or to a method of inducing a T cell immune response, using such an immunogen. The invention further relates to nucleic acid sequences encoding the present immunogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.